{"disease":{"id":"2019-novel-coronavirus","name":"2019 novel coronavirus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05615792","title":"Observational Cohort of COVID-19 Patients in Hubei Province","phase":"","overall_status":"COMPLETED","enrollment_count":68000,"lead_sponsor_name":"Dao Wen Wang","has_results":false},{"nct_id":"NCT05569408","title":"eVusheld Assessment reaL wORld Effectiveness in DoD Health System","phase":"","overall_status":"COMPLETED","enrollment_count":4724,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT04275388","title":"Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia","phase":"","overall_status":"UNKNOWN","enrollment_count":426,"lead_sponsor_name":"Jiangxi Qingfeng Pharmaceutical Co. Ltd.","has_results":false},{"nct_id":"NCT05375773","title":"Povidone Iodine Nasal Irrigation and Gargling to Reduce Viral Load in Asymptomatic Patients With COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05113810","title":"The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Ministry of Health Jordan","has_results":false},{"nct_id":"NCT04273646","title":"Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05722678","title":"Study and Analysis of Acute Pancreatitis Complicated With COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Yuansong Sun","has_results":false},{"nct_id":"NCT04778059","title":"Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"US Biotest, Inc.","has_results":true},{"nct_id":"NCT04334967","title":"Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care","phase":"PHASE4","overall_status":"SUSPENDED","enrollment_count":13,"lead_sponsor_name":"Providence Health & Services","has_results":false},{"nct_id":"NCT05077969","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":true},{"nct_id":"NCT05077332","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":false},{"nct_id":"NCT05085574","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Leidos Life Sciences","has_results":false},{"nct_id":"NCT04285190","title":"The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tasly Pharmaceuticals, Inc.","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}